SCHEMBL20702196

SCHEMBL20702196

CCCCC(=O)CC(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.47
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
CYP1A2 P05177 1/20 0.41
HAO1 Q9UJM8 1/20 0.39
ALDH1A1 P00352 2/20 0.39
AKR1B1 P15121 1/20 0.39
TP53 P04637 1/20 0.39
CA2 P00918 1/20 0.39
MAPK1 P28482 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
FFAR1 O14842 1/20 0.38
PPARG P37231 3/20 0.38
PPARD Q03181 3/20 0.38
PPARA Q07869 3/20 0.38
TSHR P16473 2/20 0.38
GPR84 Q9NQS5 2/20 0.38
HDAC11 Q96DB2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2719718 1.00 ACE2 (0.47) ACE2KMT2AMAPTCES2CES1
SCHEMBL8660353 0.94 KMT2A (0.52) ACE2KMT2AMAPTHAO1ALDH1A1
SCHEMBL12971057 0.92 KMT2A (0.55) ACE2KMT2AMAPTHAO1ALDH1A1
SCHEMBL12970932 0.92 KMT2A (0.55) ACE2KMT2AMAPTHAO1ALDH1A1
SCHEMBL8659413 0.92 KMT2A (0.55) ACE2KMT2AMAPTHAO1ALDH1A1
SCHEMBL8658977 0.92 KMT2A (0.55) ACE2KMT2AMAPTHAO1ALDH1A1
SCHEMBL27970840 0.86 CYP1A2 (0.44) ACE2CES2CES1CYP1A2TSHR
Valeric Acid SCHEMBL28674089 0.81 AKR1B1 (0.54) ACE2KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL21596754 0.80 ACE2 (0.39) ACE2KMT2AMAPTCES2CES1
SCHEMBL2049922 0.79 CES1 (0.48) ACE2KMT2AMAPTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10925846-B2 Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis Liminal Biosciences Limited (GB) 2021-02-23 US disclosed
US-20190038580-A1 PHENYLKETONE CARBOXYLATE COMPOUNDS AND PHARAMCEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS Liminal Biosciences Limited (GB) 2019-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10925846-B2 Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis NCEH1, CTSH, BCKDK ACE2 2926/4885KMT2A 1795/4885MAPT 3934/4885
US-20190038580-A1 PHENYLKETONE CARBOXYLATE COMPOUNDS AND PHARAMCEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS PAH, NCEH1, CCNH ACE2 2449/4885KMT2A 1568/4885MAPT 3324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.